WASHINGTON — A combination of nonsteroidal anti-inflammatory drugs and TNF-inhibitors may help slow down spine damage in ankylosing spondylitis, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington. Ankylosing spondylitis (AS) is an inflammatory form of arthritis that frequently affects the joints of the spine....